[go: up one dir, main page]

NL8500628A - Antipsychotische 1-fluorfenylbutyl-4-(2-pyrimidinyl) piperazinederivaten. - Google Patents

Antipsychotische 1-fluorfenylbutyl-4-(2-pyrimidinyl) piperazinederivaten. Download PDF

Info

Publication number
NL8500628A
NL8500628A NL8500628A NL8500628A NL8500628A NL 8500628 A NL8500628 A NL 8500628A NL 8500628 A NL8500628 A NL 8500628A NL 8500628 A NL8500628 A NL 8500628A NL 8500628 A NL8500628 A NL 8500628A
Authority
NL
Netherlands
Prior art keywords
formula
fluorophenyl
compound
fluoro
compound according
Prior art date
Application number
NL8500628A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8500628A publication Critical patent/NL8500628A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Legs For Furniture In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8500628A 1984-03-06 1985-03-06 Antipsychotische 1-fluorfenylbutyl-4-(2-pyrimidinyl) piperazinederivaten. NL8500628A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58658084A 1984-03-06 1984-03-06
US58658084 1984-03-06
US06/683,309 US4605655A (en) 1984-03-06 1984-12-18 Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US68330984 1984-12-18

Publications (1)

Publication Number Publication Date
NL8500628A true NL8500628A (nl) 1985-10-01

Family

ID=27079753

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8500628A NL8500628A (nl) 1984-03-06 1985-03-06 Antipsychotische 1-fluorfenylbutyl-4-(2-pyrimidinyl) piperazinederivaten.

Country Status (27)

Country Link
US (1) US4605655A (sv)
KR (3) KR920005113B1 (sv)
AT (1) AT390951B (sv)
AU (1) AU576555B2 (sv)
BE (1) BE901880A (sv)
CA (1) CA1256871A (sv)
CH (1) CH663022A5 (sv)
CY (1) CY1545A (sv)
DE (1) DE3507983A1 (sv)
DK (1) DK166149C (sv)
ES (1) ES8607254A1 (sv)
FI (1) FI84478C (sv)
FR (1) FR2560878B1 (sv)
GB (1) GB2155925B (sv)
GR (1) GR850561B (sv)
HK (1) HK82890A (sv)
HU (1) HU193949B (sv)
IE (1) IE58338B1 (sv)
IT (1) IT1183483B (sv)
LU (1) LU85796A1 (sv)
MX (1) MX9203177A (sv)
MY (1) MY102240A (sv)
NL (1) NL8500628A (sv)
PT (1) PT80058B (sv)
SE (1) SE462429B (sv)
SG (1) SG35590G (sv)
ZA (1) ZA851486B (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
MX173180B (es) * 1987-10-26 1994-02-07 Pfizer Procedimiento para preparar agentes ansioliticos
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IE64038B1 (en) * 1989-04-22 1995-06-28 Wyeth John & Brother Ltd Tertiary alkyl functionalized piperazine derivatives
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5646281A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
EP0538693A3 (en) * 1991-10-23 1994-08-17 Squibb & Sons Inc Stereoselective preparation of halophenyl alcohols
TW217382B (sv) * 1991-10-24 1993-12-11 Bristol Myers Squibb Co
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
EP0757040A4 (en) * 1994-04-18 1997-07-16 Asahi Chemical Ind ADAMANTANE DERIVATIVE, PROCESS FOR PRODUCTION AND USE OF SAID DERIVATIVE
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2104509B1 (es) * 1995-06-13 1998-07-01 Ferrer Int Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
PT2155736E (pt) * 2007-05-14 2012-03-28 Sk Biopharmaceuticals Co Ltd Novo composto carbamoiloxiarilalcanoilarilpiperazina, composições farmacêuticas compreendendo este composto e método para tratamento da dor, ansiedade e depressão pela administração do composto
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
EP4153209A1 (en) 2020-05-20 2023-03-29 The Board of Trustees of the University of Illinois Method for treating lysosomal storage diseases with histatin peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2973360A (en) * 1959-10-12 1961-02-28 Paul A J Janssen Certain 1-(2-theonyl lower alkyl)-4-(heterocyclic substituted)-piperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
NL127996C (sv) * 1963-11-19
GB1259685A (en) * 1969-04-03 1972-01-12 Soc D Etudes Prod Chimique Amino-pyrimidine derivatives
BE758380A (fr) * 1969-11-04 1971-04-16 Sumitomo Chemical Co Procede de preparation de derives d'aryl-cetones
GB1307256A (en) * 1970-09-15 1973-02-14 Science Union & Cie Piperazine derivatives and a process for their preparation
BE882836A (fr) * 1979-05-15 1980-08-18 Soc D Etudes Prod Chimique Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique
US4316899A (en) * 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
US4605655A (en) 1986-08-12
DK166149C (da) 1993-08-09
FI850850L (fi) 1985-09-07
SE8501067L (sv) 1985-09-07
ATA64985A (de) 1990-01-15
FI850850A0 (fi) 1985-03-01
ES540901A0 (es) 1986-05-16
SG35590G (en) 1990-07-13
GB8505662D0 (en) 1985-04-03
MY102240A (en) 1992-05-15
KR850006402A (ko) 1985-10-05
HUT37781A (en) 1986-02-28
FR2560878A1 (fr) 1985-09-13
CY1545A (en) 1991-03-22
KR920005694B1 (ko) 1992-07-13
FR2560878B1 (fr) 1988-10-14
DE3507983A1 (de) 1985-09-12
DK100685A (da) 1985-09-07
HK82890A (en) 1990-10-19
FI84478C (sv) 1991-12-10
MX9203177A (es) 1992-07-01
SE462429B (sv) 1990-06-25
KR920005113B1 (ko) 1992-06-26
PT80058A (en) 1985-04-01
IT1183483B (it) 1987-10-22
GB2155925B (en) 1987-11-25
AU3944985A (en) 1985-09-12
DK166149B (da) 1993-03-15
KR920005114B1 (ko) 1992-06-26
PT80058B (pt) 1987-10-20
CH663022A5 (de) 1987-11-13
IT8519773A0 (it) 1985-03-05
IE850546L (en) 1985-09-06
SE8501067D0 (sv) 1985-03-05
GR850561B (sv) 1985-07-03
ES8607254A1 (es) 1986-05-16
LU85796A1 (fr) 1985-12-12
AT390951B (de) 1990-07-25
DK100685D0 (da) 1985-03-05
ZA851486B (en) 1985-11-27
BE901880A (fr) 1985-09-05
AU576555B2 (en) 1988-09-01
FI84478B (fi) 1991-08-30
GB2155925A (en) 1985-10-02
IE58338B1 (en) 1993-09-08
CA1256871A (en) 1989-07-04
HU193949B (en) 1987-12-28

Similar Documents

Publication Publication Date Title
NL8500628A (nl) Antipsychotische 1-fluorfenylbutyl-4-(2-pyrimidinyl) piperazinederivaten.
NL193283C (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
TW577880B (en) Novel carboxylic acid derivatives, their preparation and use
AU763960B2 (en) Pyrrolidine derivatives-CCR-3 receptor antagonists
US5159083A (en) Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
JP3880842B2 (ja) 1−〔(4−クロロフェニル)フェニルメチル〕ピペラジンの鏡像体およびその製造法
AU643765B2 (en) 1-indolylalkyl-4-(alkoxypyprimidinyl)piperazines
NO162384B (no) Analogifremgangsmaate til fremstilling av 1-hetero-aryl-4-(2,5-pyrrolidinion-1-yl)-alkyl)piperazinderivater.
NL8204910A (nl) Benzisothiazool en benzisoxazoolpiperazinederivaten.
US4678787A (en) 4H-1-benzopyran-4-ones and their sulfur containing analogs
EP0433149B1 (fr) Antagonistes de la sérotonine, leur préparation et les médicaments les contenant
HU190827B (en) Process for preparing 2-/4/-/4,4-dialkyl-1,2,6-piperidindion-1-yl/-butyl/-1-piperazinyl/-pyridines
JP3004727B2 (ja) ドパミン作動性活性を有するベンゾイミダゾール誘導体
CA2541131C (fr) Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPS6334152B2 (sv)
CA1260933A (en) Bicyclic lactams, processes for their preparation and their use, and formulations containing these compounds
US5773448A (en) Pharmaceutical compounds
CA2324268A1 (en) Aromaheterocyclic derivatives
WO1994011363A1 (en) 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivative, process for producing the same, and use thereof
US4639453A (en) Substituted 1-(4-amino-6,7-dialkoxyquinazolinyl)-4 cyclohexenyl derivatives of piperazine and homopiperazine, processes for their preparation and their use, formulations containing these compounds and intermediates
JPH05345764A (ja) 新規アゼピン誘導体、その製造法およびその用途
JPS5939877A (ja) 新規なピリミドン誘導体及びその製造方法
WO1994011356A1 (en) 2-alkoxytetrahydroquinoxaline derivative, process for producing the same, and use thereof
JPH07252220A (ja) ピロリジノン誘導体

Legal Events

Date Code Title Description
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable